These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20215139)

  • 1. When does rheumatoid arthritis start and can it be stopped before it does?
    Bykerk VP; Hazes JM
    Ann Rheum Dis; 2010 Mar; 69(3):473-5. PubMed ID: 20215139
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 3. What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?
    Bobbio-Pallavicini F; Caporali R; Bugatti S; Montecucco C
    J Rheumatol; 2008 Oct; 35(10):1903-5. PubMed ID: 18843754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress in early diagnosis of rheumatoid arthritis].
    Kondo H; Sakai M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():289-92. PubMed ID: 15799363
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis.
    Spadaro A; Riccieri V
    Ann Rheum Dis; 2005 Aug; 64(8):1241-2. PubMed ID: 16014691
    [No Abstract]   [Full Text] [Related]  

  • 6. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.
    Mikuls TR; O'Dell JR; Stoner JA; Parrish LA; Arend WP; Norris JM; Holers VM
    Arthritis Rheum; 2004 Dec; 50(12):3776-82. PubMed ID: 15593224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterpoint from the trenches: a pragmatic approach to therapeutic trials in rheumatoid arthritis.
    Strand V
    Arthritis Rheum; 2004 Apr; 50(4):1344-7. PubMed ID: 15077319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arthralgia plus positive treatment of rheumatoid arthritis - yes].
    Gaubitz M
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1842. PubMed ID: 25181000
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
    Wolfe F; Michaud K
    Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 12. [Levamisole used in rheumatoid arthritis].
    Veys EM; Mielants H
    Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
    [No Abstract]   [Full Text] [Related]  

  • 13. Key randomized trials of single agents in early rheumatoid arthritis.
    van de Putte LB
    J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arthralgia plus positive treatment of rheumatoid arthritis - no].
    Specker Ch
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1843. PubMed ID: 25181001
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 17. In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis.
    Suarez-Almazor ME
    J Rheumatol; 2002 Feb; 29(2):209-11. PubMed ID: 11838836
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anakinra in the treatment of rheumatoid arthritis].
    Loft AG; Tarp U; Thomsen BS
    Ugeskr Laeger; 2003 Sep; 165(39):3720-4. PubMed ID: 14558384
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.